U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07645430) titled 'Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib.' on June 09.
Brief Summary: The primary objective of this study was to evaluate the change in serum interferon gamma and Interleukin-15 levels before and after use of oral drug baricitinib therapy. Venous blood samples (5 mL) were collected from each participant at baseline and at six months.
Study Start Date: Jan. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Alopecia Areata
Intervention:
DRUG: Baricitinib 4 MG Oral Tablet
All cases will use oral Baricitinab 4mg daily dose for six months.
Recruitment Status: COMPLETED
Sponso...